Regardless of a viral, autoimmune, or chemotherapy-induced trigger, many inflammatory cardiac diseases converge on NLRP3 activation and the release of pro-inflammatory cytokines such as IL-1β and IL-18. This evidence concerns the gene NLRP3 and heart disorder.